Usability of CHA2DS2VASC score in predicting the effectiveness and safety of pharmacological cardioversion – data from the multicenter cardioversion with intravenous ANTazoline study
In this retrospective sub-analysis of the CANT II registry, success of pharmacological cardioversion of AF is not associated with number of comorbidities as assessed by the CHA2DS2VASc score. PCV remains a feasible and generally safe option in emergency and cardiology department practice.
Authors
- Robert Błaszczyk (ORCID: https://orcid.org/0000-0003-1853-5006)
- Paweł Balsam (ORCID: https://orcid.org/0000-0003-0441-8976)
- Maciej Wójcik (ORCID: https://orcid.org/0000-0002-5092-7811)
- Edyta Ćwiek-Rębowska
- Dawid Miśkowiec (ORCID: https://orcid.org/0000-0001-8327-9550)
- Marek Szołkiewicz (ORCID: https://orcid.org/0000-0002-0367-4014)
- Hanna Szwed (ORCID: https://orcid.org/0000-0001-7888-5708)
- Katarzyna Mizia‐Stec (ORCID: https://orcid.org/0000-0001-6907-2799)
- Krzysztof Ozierański (ORCID: https://orcid.org/0000-0002-3848-0922)
- Bartosz Krzowski (ORCID: https://orcid.org/0000-0001-9987-870X)
- Michał Peller (ORCID: https://orcid.org/0000-0002-8519-3707)
- Marek Koziński (ORCID: https://orcid.org/0000-0002-6460-4802)
- Maciej Wybraniec (ORCID: https://orcid.org/0000-0003-1151-8385)
- Michał M. Farkowski (ORCID: https://orcid.org/0000-0003-1673-7712)
- Wojciech Wróbel
- Jarosław D. Kasprzak (ORCID: https://orcid.org/0000-0002-5850-8187)
- Beata Ceynowa-Sielawko
- Aleksander Maciąg
Institutions
- Medical University of Lublin (PL)
- Medical University of Silesia (PL)
- Medical University of Warsaw (PL)
- Medical University of Lodz (PL)
- Ministry of Interior and Administration (PL)
- Institute of Cardiology (PL)
- Gdansk University of Physical Education and Sport (PL)
- Foundation of Cardiac Surgery Development (PL)
- Corona (Poland) (PL)
- Gdańsk Medical University (PL)
Publication Details
- Journal
- Frontiers in Cardiovascular Medicine
- Published
- 2025-10-20
- DOI
- https://doi.org/10.3389/fcvm.2025.1648549
- Primary Topic
- Atrial Fibrillation Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00